Ursula Müller‐Vieira

1.8k total citations
29 papers, 1.5k citations indexed

About

Ursula Müller‐Vieira is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Ursula Müller‐Vieira has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 13 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Genetics. Recurrent topics in Ursula Müller‐Vieira's work include Pharmacogenetics and Drug Metabolism (13 papers), Estrogen and related hormone effects (11 papers) and Hormonal Regulation and Hypertension (11 papers). Ursula Müller‐Vieira is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Estrogen and related hormone effects (11 papers) and Hormonal Regulation and Hypertension (11 papers). Ursula Müller‐Vieira collaborates with scholars based in Germany, United States and Sweden. Ursula Müller‐Vieira's co-authors include Rolf W. Hartmann, Klaus M. Biemel, Katrin Zeilinger, Andreas K. Nüssler, Iris Antes, Sandrine Marchais‐Oberwinkler, Daniel Knobeloch, Matthias Negri, Jörg C. Gerlach and Thomas Lauterbach and has published in prestigious journals such as Journal of Medicinal Chemistry, Biotechnology and Bioengineering and European Journal of Medicinal Chemistry.

In The Last Decade

Ursula Müller‐Vieira

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ursula Müller‐Vieira Germany	24	454	422	397	324	292	29	1.5k
Núria Jiménez Spain	24	661 1.5×	168 0.4×	385 1.0×	123 0.4×	26 0.1×	33	1.7k
Xiao-bo Zhong United States	12	567 1.2×	55 0.1×	335 0.8×	72 0.2×	78 0.3×	13	1.3k
Wenwei Lin United States	23	645 1.4×	292 0.7×	435 1.1×	35 0.1×	254 0.9×	61	1.4k
Wen‐Xu Hong China	20	759 1.7×	79 0.2×	171 0.4×	45 0.1×	102 0.3×	77	1.5k
Dean Hickman United States	20	691 1.5×	43 0.1×	316 0.8×	197 0.6×	72 0.2×	39	1.6k
Sergio C. Chai United States	23	625 1.4×	247 0.6×	475 1.2×	17 0.1×	231 0.8×	49	1.4k
Yang Sai China	17	427 0.9×	39 0.1×	297 0.7×	119 0.4×	24 0.1×	44	1.0k
Paul D. van Poelje United States	23	1.1k 2.4×	436 1.0×	89 0.2×	10 0.0×	65 0.2×	33	2.1k
David B. Duignan United States	17	278 0.6×	37 0.1×	478 1.2×	207 0.6×	13 0.0×	25	1.1k
Toshiro Nishida United States	24	1.0k 2.2×	167 0.4×	34 0.1×	51 0.2×	116 0.4×	70	2.0k

Countries citing papers authored by Ursula Müller‐Vieira

Since Specialization

Citations

This map shows the geographic impact of Ursula Müller‐Vieira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Müller‐Vieira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Müller‐Vieira more than expected).

Fields of papers citing papers by Ursula Müller‐Vieira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ursula Müller‐Vieira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Müller‐Vieira. The network helps show where Ursula Müller‐Vieira may publish in the future.

Co-authorship network of co-authors of Ursula Müller‐Vieira

This figure shows the co-authorship network connecting the top 25 collaborators of Ursula Müller‐Vieira. A scholar is included among the top collaborators of Ursula Müller‐Vieira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ursula Müller‐Vieira. Ursula Müller‐Vieira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lester, Cathy, Nicola J. Hewitt, Ursula Müller‐Vieira, et al.. (2020). Metabolism and plasma protein binding of 16 straight- and branched-chain parabens in in vitro liver and skin models. Toxicology in Vitro. 72. 105051–105051. 14 indexed citations

Kühnl, Jochen, Ursula Müller‐Vieira, Camille Géniès, et al.. (2020). Characterization of application scenario-dependent pharmacokinetics and pharmacodynamic properties of permethrin and hyperforin in a dynamic skin and liver multi-organ-chip model. Toxicology. 448. 152637–152637. 42 indexed citations

Schyschka, Lilianna, Britta Burkhardt, Ursula Müller‐Vieira, et al.. (2013). Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity. Archives of Toxicology. 87(8). 1581–1593. 94 indexed citations

Lübberstedt, Marc, Ursula Müller‐Vieira, Klaus M. Biemel, et al.. (2012). Serum-free culture of primary human hepatocytes in a miniaturized hollow-fibre membrane bioreactor for pharmacologicalin vitrostudies. Journal of Tissue Engineering and Regenerative Medicine. 9(9). 1017–1026. 41 indexed citations

Hoffmann, Stefan A., Ursula Müller‐Vieira, Klaus M. Biemel, et al.. (2012). Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies. Biotechnology and Bioengineering. 109(12). 3172–3181. 55 indexed citations

Mueller, Daniel, Ursula Müller‐Vieira, Klaus M. Biemel, et al.. (2012). Biotransformation of diclofenac and effects on the metabolome of primary human hepatocytes upon repeated dose exposure. European Journal of Pharmaceutical Sciences. 45(5). 716–724. 19 indexed citations

Mueller, Daniel, Georg Tascher, Ursula Müller‐Vieira, et al.. (2011). In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor. Journal of Tissue Engineering and Regenerative Medicine. 5(8). e207–e218. 31 indexed citations

Rižner, Tea Lanišnik, Petra Brožič, Ursula Müller‐Vieira, et al.. (2011). Selectivity and potency of the retroprogesterone dydrogesterone in vitro. Steroids. 76(6). 607–615. 67 indexed citations

Lübberstedt, Marc, Ursula Müller‐Vieira, Klaus M. Biemel, et al.. (2010). HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro. Journal of Pharmacological and Toxicological Methods. 63(1). 59–68. 180 indexed citations

10.

Fatima, Noor, Jens Niklas, Ursula Müller‐Vieira, & Elmar Heinzle. (2009). An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells. Toxicology and Applied Pharmacology. 237(2). 221–231. 46 indexed citations

11.

Hille, Ulrike E., Qingzhong Hu, Carsten A. Vock, et al.. (2009). Novel CYP17 inhibitors: Synthesis, biological evaluation, structure–activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls. European Journal of Medicinal Chemistry. 44(7). 2765–2775. 57 indexed citations

12.

Fatima, Noor, et al.. (2009). High throughput, non-invasive and dynamic toxicity screening on adherent cells using respiratory measurements. Toxicology in Vitro. 24(2). 686–694. 29 indexed citations

13.

Miranda, Joana P., Sofia Batista Leite, Ursula Müller‐Vieira, et al.. (2008). Towards an Extended Functional Hepatocyte In Vitro Culture. Tissue Engineering Part C Methods. 15(2). 157–167. 68 indexed citations

14.

Frotscher, Martin, Erika Ziegler, Sandrine Marchais‐Oberwinkler, et al.. (2008). Design, Synthesis, and Biological Evaluation of (Hydroxyphenyl)naphthalene and -quinoline Derivatives: Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) for the Treatment of Estrogen-Dependent Diseases. Journal of Medicinal Chemistry. 51(7). 2158–2169. 80 indexed citations

15.

Hu, Qingzhong, Matthias Negri, Yan Zhuang, et al.. (2008). Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17α-hydroxylase-17,20-lyase (CYP17)—Part II: Core rigidification and influence of substituents at the methylene bridge. Bioorganic & Medicinal Chemistry. 16(16). 7715–7727. 49 indexed citations

16.

Negri, Matthias, Qingzhong Hu, Ulrike E. Hille, et al.. (2008). CYP17 Inhibitors. Annulations of Additional Rings in Methylene Imidazole Substituted Biphenyls: Synthesis, Biological Evaluation and Molecular Modelling. Archiv der Pharmazie. 341(10). 597–609. 21 indexed citations

17.

Jagusch, Carsten, Matthias Negri, Ulrike E. Hille, et al.. (2007). Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17α-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structure. Bioorganic & Medicinal Chemistry. 16(4). 1992–2010. 74 indexed citations

18.

Müller‐Vieira, Ursula, et al.. (2005). Synthesis and Evaluation of (Pyridylmethylene)tetrahydronaphthalenes/-indanes and Structurally Modified Derivatives: Potent and Selective Inhibitors of Aldosterone Synthase. Journal of Medicinal Chemistry. 48(5). 1563–1575. 67 indexed citations

19.

Müller‐Vieira, Ursula, et al.. (2005). The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYP11B1 (steroid-11β-hydroxylase) inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 96(3-4). 259–270. 29 indexed citations

20.

Voets, Marieke, Ursula Müller‐Vieira, Sandrine Marchais‐Oberwinkler, & Rolf W. Hartmann. (2004). Synthesis of Amidinohydrazones and Evaluation of Their Inhibitory Effect towards Aldosterone Synthase (CYP11B2) and the Formation of Selected Steroids. Archiv der Pharmazie. 337(7). 411–416. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact